Department of Vascular and Endovascular Surgery, Kauvery Hospital, Chennai, India.
Department of Vascular and Endovascular Surgery, Kauvery Hospital, Chennai, India.
Ann Vasc Surg. 2024 Sep;106:321-332. doi: 10.1016/j.avsg.2024.03.014. Epub 2024 May 28.
In India, a significant scarcity of published data exists regarding chronic limb-threatening ischemia (CLTI) and its management, especially among the elderly population. CLTI, often accompanied by frailty poses a significant healthcare challenge. While endovascular interventions offer hope, there remains a dearth of outcome data for this age group. This study seeks to address this critical gap by investigating the impact of frailty on outcomes, emphasizing amputation-free survival (AFS), wound healing, and health-related quality of life (HRQoL).
Our study included 131 elderly CLTI patients aged ≥70 years who underwent infrainguinal endovascular interventions between April 2018 and August 2021, with a follow-up period of 2 years. Among the patients, 93.9% had diabetes mellitus and 82.4% had hypertension. Clinical frailty was assessed using the clinical frailty scale (CFS). Patients were categorized into group 1 (CFS 1-5) and group 2 (CFS 6-9). Primary outcomes were AFS, wound healing, HRQoL, and their association with frailty. Secondary outcomes included technical success, procedure-related complications, major adverse limb events, major adverse cardiac events, vessel patency, re-intervention rates, and mortality rates including periprocedural and overall mortality.
Technical success was achieved in 86.3% of patients, with frailty significantly influencing this outcome. Group 2 exhibited reduced technical success (80.8%) compared to group 1 (93.1%). The major amputation rate was 9.2%, with higher rates in group 2 [univariate hazard ratio: 5.20; P = 0.033]. Similarly, group 2 showed elevated overall mortality [univariate hazard ratio: 5.18; P < 0.001]. AFS at 1 and 2 years were 67.9% and 55%, respectively, with higher rates in group 1. Wound healing was achieved in 76.1% of patients (83/109), with frailty significantly associated with delayed wound healing (P < 0.001). Vessel patency at 1 year was observed in 88.8% of patients. HRQoL significantly improved postintervention, with vascular quality of life questionnaire-6 (VascuQol-6) scores increasing from an average of 9 of 24 at baseline to 20 of 24 at 2 years. Frailty score significantly correlated with VascuQol-6 scores at 1 and 2 years (P < 0.0012). Group 1 exhibited higher VascuQol-6 scores than group 2, indicating improved HRQoL during follow-up.
Successful endovascular treatments in high-risk CLTI patients promote improved wound healing and post-treatment quality of life. Frailty should be assessed before endovascular interventions as it correlates with adverse outcomes, including amputations and mortality. While revascularization holds promise, caution is advised for frailer patients, emphasizing the importance of personalized care and tailored treatments for elderly CLTI patients.
在印度,有关慢性肢体威胁性缺血(CLTI)及其管理的已发表数据严重匮乏,尤其是在老年人群中。CLTI 常伴有虚弱,这对医疗保健构成了重大挑战。虽然血管内介入治疗带来了希望,但针对这一年龄组的治疗效果数据仍然缺乏。本研究旨在通过调查虚弱对结局的影响来解决这一关键差距,重点关注免于截肢的生存(AFS)、伤口愈合和与健康相关的生活质量(HRQoL)。
我们的研究纳入了 131 名年龄≥70 岁的老年 CLTI 患者,这些患者在 2018 年 4 月至 2021 年 8 月期间接受了下肢血管内介入治疗,随访期为 2 年。这些患者中,93.9%患有糖尿病,82.4%患有高血压。采用临床虚弱量表(CFS)评估临床虚弱。患者分为第 1 组(CFS 1-5)和第 2 组(CFS 6-9)。主要结局是 AFS、伤口愈合、HRQoL 及其与虚弱的关系。次要结局包括技术成功率、与手术相关的并发症、主要肢体不良事件、主要心脏不良事件、血管通畅性、再干预率和死亡率,包括围手术期和总死亡率。
86.3%的患者达到了技术成功,虚弱显著影响了这一结果。第 2 组的技术成功率(80.8%)低于第 1 组(93.1%)。主要截肢率为 9.2%,第 2 组的截肢率更高[单因素风险比:5.20;P=0.033]。同样,第 2 组的总死亡率也较高[单因素风险比:5.18;P<0.001]。1 年和 2 年的 AFS 分别为 67.9%和 55%,第 1 组的 AFS 更高。76.1%(83/109)的患者伤口愈合,虚弱与伤口愈合延迟显著相关(P<0.001)。1 年时血管通畅率为 88.8%。HRQoL 治疗后显著改善,血管生活质量问卷-6(VascuQol-6)评分从基线时的平均 24 分中的 9 分增加到 2 年后的 20 分。虚弱评分与 1 年和 2 年的 VascuQol-6 评分显著相关(P<0.0012)。第 1 组的 VascuQol-6 评分高于第 2 组,表明在随访期间 HRQoL 得到改善。
在高危 CLTI 患者中成功的血管内治疗可促进伤口愈合和治疗后生活质量的改善。血管内介入治疗前应评估虚弱情况,因为它与不良结局相关,包括截肢和死亡。虽然血管重建术有一定前景,但对于虚弱的患者应谨慎,强调为老年 CLTI 患者提供个性化护理和量身定制的治疗的重要性。